IRCT2017042927797N2 IRCT 2017-06-07 Vice Chancellor of Reaserch and Technology, Babol University of Medical Sciences Comparison of subacromial Ketorolac, betamethazone LA and triamcinolon injection in treatment of impingement syndrome Comparison of subacromial Ketorolac, betamethazone LA and triamcinolon injection in treatment of impingement syndrome 2016-10-03 anticipated 105 Complete https://irct.ir/trial/22702 interventional Randomization: Randomized, Blinding: Double blinded, Placebo: Not used, Assignment: Parallel, Purpose: Treatment. 2 Impingement syndrome of shoulder. Intervention 1: In Group A subacromial ketorolac injection with a posterior approach will be done. Intervention 2: In Group B subacromial Triamcinolon injection with a posterior approach will be done. Intervention 3: In Group C subacromial Betamethazon LA injection with a posterior approach will be done.

public Dr.Hamed Abolhassani

Babol University of Medical Sciences, Ganjafrooz Street, Babol, Iran

Babol Iran (Islamic Republic of) +98 11 3219 7667 bcrdc90@yahoo.com Babol University of Medical Sciences scientific Dr. Masoud Bahrami Frydoni

Babol University of Medical Sciences, Ganjafrooz Street, Babol, Iran

Babol Iran (Islamic Republic of) +98 11 3219 7667 Dr bahrami865@gmail.com Babol University of Medical Sciences Iran (Islamic Republic of) Inclusion criteria: all people with shoulder pain referred to orthopedic clinics and diagnostic imaging in the diagnosis of shoulder impingement syndrome has been laid for them and their consent to participate in the study. Exclusion criteria: patients with all of the diagnosis except impingement syndrome; Do not go to the next follow up; do not have a history of shoulder dislocation or fracture or a systemic disease that affects the joint and soft tissue . no limit no limit Both M75.4 Impingement syndrome of shoulder Treatment - Drugs Treatment - Drugs Treatment - Drugs In Group A subacromial ketorolac injection with a posterior approach will be done. In Group B subacromial Triamcinolon injection with a posterior approach will be done. In Group C subacromial Betamethazon LA injection with a posterior approach will be done. Determine the function of the patient. Timepoint: Before injection, weeks 2, 4 and 6 after injection. Method of measurement: By Oxford Shoulder Score questionnaire. Patient pain severity. Timepoint: Before injection, weeks 2, 4 and 6 after injection. Method of measurement: By Visual Analogus Scale questionnaire. Tendon Rupture. Timepoint: weeks 2, 4 and 6 after injection. Method of measurement: Physical Examination. Injection site infection. Timepoint: weeks 2, 4 and 6 after injection. Method of measurement: Observation. Vice Chancellor of Reaserch and Technology, Babol University of Medical Sciences Approved 2017-01-31 Ethics committee of Babol University of Medical Sciences Babol University of Medical Sciences, Ganjafrooz Street, Babol, Mazandaran, Iran Babol Iran (Islamic Republic of)